Pay in 4 interest-free payments of $6.03 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Semaglutide: the single-receptor approach Semaglutide is a GLP-1 receptor agonist
Gulewitch VS, Krimberg R
CLARITY FOR ACTION Gain Clarity: Navitus 10th Annual Drug Trend Report Ready to Download Our 2025 report provides transparent, data-driven insight to help plans, plan sponsors and consultants navigate an increasingly complex prescription drug landscape.
TN201, an AAV9-mediated gene therapy, aims to restore MYBPC3 protein expression by delivering a functional MYBPC3 gene
Macrophage-mediated cholesterol handling in atherosclerosis
Poorly compounded semaglutide or tirzepatide can compromise patient outcomes, raise regulatory concerns, and damage provider reputation
US$ 20.78
US$ 21.26
US$ 29.78
US$ 21.42
